ESC 365 - Atrial rates during treated ventricular tachycardia in patients with implantable cardioverter defibrillators: clinical implications of a vagal sinus node response

ESC Premium Access

Atrial rates during treated ventricular tachycardia in patients with implantable cardioverter defibrillators: clinical implications of a vagal sinus node response

Session: Implantable cardioverter defibrillators: maximising protection and quality of life

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Miss R. Martin (London, GB)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Miss Rosie Martin

London (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

Regional results of the lead evaluation for defibrillation and reliability (LEADR) trial

Speaker: Doctor P. Mason (Charlottesville, US)

Routine chest X-ray post cardiac implantable electronic device implantation: is it really required? Experience from a tertiary centre

Speaker: Ms J. Tan (London, GB)

Assessment of quality of life and ICD shock-related anxiety in Asian patients with implantable cardioverter defibrillator in the PainFree SST study

Speaker: Associate Professor Y. Kondo (Chiba, JP)

Half of implantable cardioverter-defibrillator patients remain at risk of painful shocks in the last moments of life

Speaker: Ms D. Yilmaz (Leiden, NL)

All-cause mortality and incidence of appropriate therapy from a primary preventive implantable cardioverter defibrillator in patients with non-ischemic dilated cardiomyopathy

Speaker: Doctor T. Nguyen (Oslo, NO)

Access the full session

Implantable cardioverter defibrillators: maximising protection and quality of life

Speakers: Miss R. Martin, Doctor P. Mason, Ms J. Tan, Associate Professor Y. Kondo, Ms D. Yilmaz...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources